Your browser doesn't support javascript.
loading
Disagreement FDA and EMA on RSV Maternal Vaccination: Possible Consequence for Global Mortality.
Willemsen, Joukje E; Borghans, José A M; Bont, Louis J; Drylewicz, Julia.
Affiliation
  • Willemsen JE; From the Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Borghans JAM; Division of Infectious Diseases, Department of Pediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Bont LJ; From the Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Drylewicz J; Division of Infectious Diseases, Department of Pediatrics, University Medical Centre Utrecht, Utrecht, the Netherlands.
Pediatr Infect Dis J ; 43(1): e1-e2, 2024 Jan 01.
Article in En | MEDLINE | ID: mdl-38100732
ABSTRACT
The European Medicines Agency and the US Food and Drug Administration have recently approved a maternal vaccine for respiratory syncytial virus. The US Food and Drug Administration limits vaccination to later in pregnancy. Mathematical modeling demonstrates that this vaccination window may reduce the global mortality impact of the vaccine by 12%. Policymakers should carefully consider vaccine risks and benefits to safeguard vulnerable infants effectively.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines Limits: Female / Humans / Infant / Pregnancy Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 2024 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines Limits: Female / Humans / Infant / Pregnancy Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 2024 Type: Article Affiliation country: Netherlands